Traber
Boris Traber, Ladenburg DE
Patent application number | Description | Published |
---|---|---|
20090247694 | SELF-HEALING ELASTOMER SYSTEM - A self-healing elastomer system is provided. The system includes an elastomer that has a surface and a core. The elastomer has an elastomer matrix. The elastomer matrix has first functional groups covalently bonded in the interior. A liquid phase borders on the surface of the elastomer. The liquid phase contains an additive. The first functional groups and the additive are chosen so that, in the case of damage to the elastomer, the first functional groups that come into contact with the liquid phase enter into a reaction. The invention also concerns methods for producing and using the self-healing elastomer system and suitable elastomers. | 10-01-2009 |
Bruno Traber, Munsingen CH
Patent application number | Description | Published |
---|---|---|
20100320736 | Airbag - The invention relates to an airbag with wall parts ( | 12-23-2010 |
20130221569 | Injection Molding Method for Modifying a Surface of an Apolar Polymer Molded Body, and Multi-layer Foil Suitable for Said Method - The invention relates to an injection moulding method for modifying a surface of a polymer moulded part ( | 08-29-2013 |
20140014253 | Method of Making an Airbag - An airbag is made by producing a laminated material including a backing layer, a first polymer layer facing the backing layer, and a second polymer layer facing away from the backing layer. The first polymer layer has a glass transition temperature of 10° C. or less. The second polymer layer has a storage modulus at least 1 MPa at 90° C. | 01-16-2014 |
Christof Traber, Zurich CH
Patent application number | Description | Published |
---|---|---|
20090076819 | Text to speech synthesis - An input linguistic description is converted into a speech waveform by deriving at least one target unit sequence corresponding to the linguistic description, selecting from a waveform unit database for the target unit sequences a plurality of alternative unit sequences approximating the target unit sequences, concatenating the alternative unit sequences to alternative speech waveforms and presenting the alternative speech waveforms to an operating person and enabling the choice of one of the presented alternative speech waveforms. There are no iterative cycles of manual modification and automatic selection, which enables a fast way of working. The operator does not need knowledge of units, targets, and costs, but chooses from a set of given alternatives. The fine-tuning of TTS prompts therefore becomes accessible to non-experts. | 03-19-2009 |
20130132069 | Text To Speech Synthesis for Texts with Foreign Language Inclusions - A speech output is generated from a text input written in a first language and containing inclusions in a second language. Words in the native language are pronounced with a native pronunciation and words in the foreign language are pronounced with a proficient foreign pronunciation. Language dependent phoneme symbols generated for words of the second language are replaced with language dependent phoneme symbols of the first language, where said replacing includes the steps of assigning to each language dependent phoneme symbol of the second language a language independent target phoneme symbol, mapping to each one language independent target phoneme symbol a language independent substitute phoneme symbol assignable to a language dependent substitute phoneme symbol of the first language, substituting the language dependent phoneme symbols of the second language by the language dependent substitute phoneme symbols of the first language. | 05-23-2013 |
Daniel L. Traber, Galveston, TX US
Patent application number | Description | Published |
---|---|---|
20080230053 | PULSE DRUG NEBULIZATION SYSTEMS, FORMULATIONS THEREFORE, AND METHODS OF USE - Liquid nebulizer apparatus, systems, and formulation compositions, as well as systems for the nebulized, aerosol delivery of such compositions, for the administration and insufflation of medicinal aerosols into the pulmonary system of a mammal are described. The nebulizing apparatus and system can effectively aerosolize a variety of viscosities of medicinal liquid drug carriers, including those made up of oil, water, or emulsions of oil and water. Drugs dissolved or suspended in the compositions and formulations described and adapted for use herein are not damages or denatured by the nebulization process when the nebulizer described is used. Further, the nebulization system itself can be adapted for use with both mechanically assisted pulmonary ventilation systems as well as hand-held inhalers and nose/mouth face masks for use in pulmonary drug delivery. | 09-25-2008 |
20090221475 | Treatment of lung disorders - The invention features methods of treating a subject having a lung disorder such as lung inflammation and injury, by administering antithrombin III by inhalation. | 09-03-2009 |
20110070167 | METHOD OF PREVENTING FIBRIN CLOTS IN PULMONARY TISSUE THROUGH THE USE OF AEROSOLIZED ANTICOAGULANTS - ATIII is a serine proteinase inhibitor (serpin) with anti-coagulant, anti-inflammatory, anti-proliferative and anti-angiogenic properties. The invention features methods of treating a subject having lung injury due to burns and smoke inhalation by administering a synergistic combination of antithrombin III and heparin through pulmonary delivery means. | 03-24-2011 |
20120111324 | Dry Powder Drug Delivery Formulations, Methods of Use, and Devices Therefore - The present disclosure relates to systems, methods, and formulations for the pulmonary administration of one or more therapeutic agents, in dry powder form, in a single, large dose quantity. These formulations, methods, and systems are useful in the treatment of patients suffering from toxic or harmful gas exposure, such as nerve gas exposure, as well as in the treatment of patients suffering from diseases of the pulmonary system, including tuberculosis, cystic fibrosis, and chronic obstructive pulmonary disease (COPD). | 05-10-2012 |
20120174915 | PULSE DRUG NEBULIZATION SYSTEM, FORMULATIONS THEREFORE, AND METHODS OF USE - Liquid nebulizer apparatus, systems, and formulation compositions, as well as systems for the nebulized, aerosol delivery of such compositions, for the administration and insufflation of medicinal aerosols into the pulmonary system of a mammal are described. The nebulizing apparatus and system can effectively aerosolize a variety of viscosities of medicinal liquid drug carriers, including those made up of oil, water, or emulsions of oil and water. Drugs dissolved or suspended in the compositions and formulations described and adapted for use herein are not damaged or denatured by the nebulization process when the nebulizer described is used. Further, the nebulization system itself can be adapted for use with both mechanically assisted pulmonary ventilation systems as well as hand-held inhalers and nose/mouth face masks for use in pulmonary drug delivery. | 07-12-2012 |
Daniel S. Traber, Galveston, TX US
Patent application number | Description | Published |
---|---|---|
20150034077 | PULSE DRUG NEBULIZATION SYSTEM, FORMULATIONS THEREFORE, AND METHODS OF USE - Liquid nebulizer apparatus, systems, and formulation compositions, as well as systems for the nebulized, aerosol delivery of such compositions, for the administration and insufflation of medicinal aerosols into the pulmonary system of a mammal are described. The nebulizing apparatus and system can effectively aerosolize a variety of viscosities of medicinal liquid drug carriers, including those made up of oil, water, or emulsions of oil and water. Drugs dissolved or suspended in the compositions and formulations described and adapted for use herein are not damaged or denatured by the nebulization process when the nebulizer described is used. Further, the nebulization system itself can be adapted for use with both mechanically assisted pulmonary ventilation systems as well as hand-held inhalers and nose/mouth face masks for use in pulmonary drug delivery. | 02-05-2015 |
Lillian D. Traber, Galveston, TX US
Patent application number | Description | Published |
---|---|---|
20090221475 | Treatment of lung disorders - The invention features methods of treating a subject having a lung disorder such as lung inflammation and injury, by administering antithrombin III by inhalation. | 09-03-2009 |
Mario Traber, Diesenhofen DE
Patent application number | Description | Published |
---|---|---|
20090237122 | Line Driver Method and Apparatus - According to one embodiment, a line driver circuit comprises a plurality of output stages each operable to produce an output signal and one or more pre-output stages operable to perform one or more common functions. The line driver circuit also comprises circuitry operable to selectively couple one or more of the output stages to the one or more pre-output stages based on a wireline communication technology implemented by the line driver circuit. | 09-24-2009 |
Peter G. Traber, Duluth, GA US
Patent application number | Description | Published |
---|---|---|
20130171151 | Galacto-rhamnogalacturonate compositions for the treatment of non-alcoholic steatohepatitis and non-alcoholic fatty liver disease - Aspects of the invention provide methods for treatment of nonalcoholic steatohepatitis and associated liver fibrosis. In particular, aspects of the invention relate to the use of a therapeutic formulation comprising a galacto-rhamnogalacturonate compound for the treatment of nonalcoholic steatohepatitis and associated liver fibrosis. | 07-04-2013 |
20130259870 | Galactomannan polysaccharide composition for the treatment of nonalcoholic steatohepatitis and nonalcoholic fatty liver disease - Aspects of the invention provides provide methods for treatment of NASH and associated liver fibrosis. In particular, aspects of the invention relate to the therapeutic formulation comprising a galactomannan polysaccharide compound for the treatment of NASH and associated liver fibrosis. | 10-03-2013 |
20130261078 | Compositions of novel carbohydrate drug for treatment of human diseases - Aspects of the invention provide compositions for use in the treatment galectin-dependent diseases. In particular, compositions comprising a selectively depolymerized, branched galactoarabino-rhamnogalacturonate whose backbone is predominantly comprised of 1,4-linked galacturonic acid (GalA) moieties, with a lesser backbone composition of alternating 1,4-linked GalA and 1,2-linked rhamnose (Rha), which in-turn is linked to any number of side chains, including predominantly 1,4-b-D-galactose (Gal) and 1,5-a-L-arabinose (Ara) residues. | 10-03-2013 |
20140086932 | METHOD FOR ENHANCING SPECIFIC IMMUNOTHERAPIES IN CANCER TREATMENT - Methods and compositions of the invention relate to the enhancement of specific immunotherapies in cancer treatment. In particular, aspects of the invention relate to novel approaches to boost immune function using a complex carbohydrate pharmaceutical compound alone or in combination with other targeted immunotherapy to increase the efficacy of immunotherapy of cancer. | 03-27-2014 |
20140350238 | COMPOSITION OF NOVEL CARBOHYDRATE DRUG FOR TREATMENT OF HUMAN DISEASES - Aspects of the invention provide compositions for use in the treatment galectin-dependent diseases. In particular, compositions comprising a selectively depolymerized, branched galactoarabino-rhamnogalacturonate whose backbone is predominantly comprised of 1,4-linked galacturonic acid (GalA) moieties, with a lesser backbone composition of alternating 1,4-linked GalA and 1,2-linked rhamnose (Rha), which in-turn is linked to any number of side chains, including predominantly 1,4-b-D-galactose (Gal) and 1,5-a-L-arabinose (Ara) residues. | 11-27-2014 |
Peter G. Traber, Norcros, GA US
Patent application number | Description | Published |
---|---|---|
20140099319 | Galactose-pronged carbohydrate compounds for the treatment of diabetic nephropathy and associated disorders - Methods and compositions of the invention relate to the treatment of diabetic nephropathy and associated disorders. In particular, the methods and compositions use a pharmaceutical-grade galactose-pronged carbohydrate or pharmaceutical compositions thereof alone or in combination with other therapeutic agents. | 04-10-2014 |
Peter G. Traber, Norcross, GA US
Patent application number | Description | Published |
---|---|---|
20140235571 | Method for treatment of pulmonary fibrosis - Methods and compositions of the invention relate to the treatment of pulmonary fibrosis. | 08-21-2014 |
Peter G. Traber, San Jose, CA US
Patent application number | Description | Published |
---|---|---|
20100230354 | METHODS AND APPARATUS FOR CENTRIFUGAL LIQUID CHROMATOGRAPHY - Apparatus and methods related to centrifugal liquid chromatography are described. An angular velocity can be simultaneously imparted to a large number of chromatographic enclosures. Via centrifugal forces, a mobile phase fluid including a sample can be driven through a stationary phase within the chromatographic enclosure to perform a chromatographic separation process on components of the sample. The use of centrifugation as a driving force can allow significantly smaller stationary phase particles to be employed as compared to high performance liquid chromatography (HPLC). Further, for an equivalent chromatographic separation process, the use of centrifugation can provide much greater separation efficiencies than HPLC. | 09-16-2010 |
Rainer Hans Traber, Reinach CH
Patent application number | Description | Published |
---|---|---|
20110296632 | AQUEOUS DYE DISPERSIONS - The present invention relates to storage stable aqueous dye dispersions, comprising (a) 2.0 to 30.0% by weight, based on the sum of (a), (b) and (c), of a dye of the formula (3) in which KK is a residue of a coupling component; (b) 0.1 to 20.0 % by weight, based on the sum of (a), (b) and (c), of at least one additive selected from the group consisting of wetting agents, dispersing agents, rheology modifiers, and preservatives; and (c) 50.0 to 97.9% by weight, based on the sum of (a), (b) and (c), of water. The invention moreover relates to a process for their preparation and the use thereof for the dyeing, in particular of paper. | 12-08-2011 |
20120005845 | AQUEOUS DIRECT DYE FORMULATIONS - The present invention relates to an aqueous direct dye formulation, comprising (a) 5 to 25% by weight of a dye composition comprising (a1) 50-99% by weight of one or more dyes obtainable by reduction or thermal treatment of Direct Yellow 11, and (a2) 1-50% by weight of a blue, black and/or red direct dye, (all based on the dye composition); (b) up to 0.9% by weight of a saturated, cyclic or acyclic water-soluble amine comprising a primary, secondary or tertiary amino group and at least one further functional group selected from primary, secondary and tertiary amino groups, OH groups and ether groups; and (c) up to 0.9% by weight of urea; and (d) water, wherein the percentages for (a), (b), and (c) relate to the total weight of the aqueous direct dye formulation. The invention moreover relates to a process for their preparation and the use thereof for the dyeing, in particular of paper, as well as paper which has been dyed with this aqueous direct dye formulation. | 01-12-2012 |
Roman Traber, Kriessern CH
Patent application number | Description | Published |
---|---|---|
20080302811 | Device for Automatically Equipping Substrates with Medical and/or Pharmaceutical and/or Food Supplementing Products and System for Automatically Producing Packaging for Medical and/or Pharmaceutical and/or Food Supplementing Products - The invention relates to an apparatus for automatically mounting substrates with medical and/or pharmaceutical and/or food-supplementing products, including at least one magazine for storing blister strips rolled up on rolls or the like, each magazine having at least one holding position for the rolls, and a delivery device for unrolling the blister strips and delivering the unrolled blister strips to a supply position for the products to be mounted being provided for each roll in the magazine, and a mounting head which can be controlled by a control system for transporting the products from the supply position to a dispensing position on the substrate, which is distinguished in that the apparatus has separating means for separating product-filled blister sections from the blister strip, and the mounting head is designed to receive, rotate and dispense the separated blister sections with the products sealed therein. Furthermore, the invention concerns a system for automatically manufacturing packages with at least one above-mentioned apparatus. | 12-11-2008 |